Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQRCT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,028
Award facts
- Contract value 100% obligated
- $12,027.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,027.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on June 20, 2025, represents a competitive procurement with no set-aside designation and carries an ultimate completion date of June 23, 2025. The place of performance is listed as the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio under the DLA IDC encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Descovy, an antiretroviral medication, exemplifies the contractor's role in fulfilling federal medical supply needs through the DLA's global pharmaceutical support vehicle, which serves customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FQRCT?
SPE2DB25FQRCT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FQRCT worth?
The government has obligated $12,028 on SPE2DB25FQRCT.
Is contract SPE2DB25FQRCT an order under another contract?
Yes. SPE2DB25FQRCT is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQRCT competed?
The extent of competition for SPE2DB25FQRCT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award